Larry Ramer

Larry Ramer

InvestorPlace Contributor

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

Why Investors Should Not Take a Ride on Virgin Galactic

By Larry Ramer, InvestorPlace Contributor

Among the challenges facing SPCE stock at this point are very tough competition and an upcoming test flight.

3 Consumer Cyclical Stocks to Buy for the Coming Travel Explosion

By Larry Ramer, InvestorPlace Contributor

Consumer cyclical stocks should expect a big boost from the CDC's recent announcement that vaccinated people can resume daily activities.

Why the Outlook of FuboTV Remains Bleak

By Larry Ramer, InvestorPlace Contributor

I continue to believe that FuboTV's addressable market is quite low. Meanwhile, its losses are mounting. Consequently, I remain bearish on FUBO stock.

Hyliion Stock Has a Good Story, but It’s Too Risky at These Prices

By Larry Ramer, InvestorPlace Contributor

There's a great deal to like about Hyliion, but the risk-reward ratio of HYLN stock is negative at this point.

Ocugen Stock Is Left Behind As the U.S. Emerges From the Pandemic

By Larry Ramer, InvestorPlace Contributor

There seems to be no need for Covaxin in the U.S. and there are no indications that the U.S. is considering approving it. Consequently, OCGN stock is worth shorting.

Nio Has Attractive Opportunities and Is Facing Tough Threats

By Larry Ramer, InvestorPlace Contributor

With the valuation of Nio stock still quite elevated and the company facing tough hurdles, it's time to sell Nio shares.

GameStop Could Fall or Tread Water, but It’s Not Going up Anytime Soon

By Larry Ramer, InvestorPlace Contributor

GameStop is taking steps to bolster its e-commerce business, but the valuation of GME stock remains excessive.

MicroVision May Be Disruptive, But Don’t Buy MVIS Stock Yet

By Larry Ramer, InvestorPlace Contributor

MicroVision is potentially disruptive. But given the extremely high valuation of MVIS stock and the market's current aversion to growth stocks, it isn't a buy yet.

Genius Brands Has Become a Buy with the Spotlight on Its Flagship Show

By Larry Ramer, InvestorPlace Contributor

GNUS stock should be bought following its recent tumble, as the company's flagship show is becoming a big success.

What QuantumScape and the Internet Pioneers Have in Common

By Larry Ramer, InvestorPlace Contributor

Amid continuing doubts about QuantumScape's technology and emerging, tough competition, investors should unload QS stock.

Load More